Results 681-690 of about 1,000
  1. CRISPR/Cas9 system is a powerful genome-editing technology for studying genetics and cell biology. Safe harbor sites are ideal genomic locations for transgene integration with minimal interference in cellular functions. Gene targeting of the AAVS1
    Date: (2022)
    Authors: Jinchao Gu , Ben Rollo , Huseyin Sumer , Brett Cromer
    Ref: Applications of Genome Modulation and Editing
  2. Date: 2023-12-02
    Authors: Luo J, Lu C, Wang M, Yang X.
    Journal: STAR protocols
  3. The discovery of CRISPR/Cas9 as an easily programmable endonuclease heralds a new era of genetic manipulation. With this comes the prospect of novel gene therapy approaches, and the potential to cure previously untreatable genetic diseases. However,
    Date: (2022)
    Authors: Matthew D. Newton , Benjamin J. Taylor , Maria Emanuela Cuomo , David S. Rueda
    Ref: Optical Tweezers
  4. Date: 2023-11-17
    Authors: Wang P, Cao Z, Wang Q, Ma X, Wang N, Chen L, Zhao Y, Miao L.
    Journal: STAR protocols
  5. CRISPR-Cas9 is a convenient tool to create knockdown mutants for desired genes. Early generations of transgenic plants usually have multiple editing events. To select the best plants for future study, these plants need to be screened for editing type
    Date: (2022)
    Authors: Junli Zhang
    Ref: Genomics of Cereal Crops
  6. Gene editing introduces stable mutations into the genome and has powerful applications extending from research to clinical gene therapy. CRISPR-Cas9 gene editing can be employed to study directly the functional impact of stable gene knockout,
    Date: (2022)
    Authors: Katherine Shortt , Daniel P. Heruth
    Ref: Hepatocytes
  7. Date: 2023-11-09
    Authors: Sahu S, Sullivan T, Southon E, Caylor D, Geh J, Sharan S.
    Journal: STAR protocols
  8. Advances in gene editing tools such as CRISPR/Cas9 have made precise in vivo gene editing possible, opening up avenues of research into somatic cell reprograming to study adult stem cells, homeostasis, and malignant transformation. Here we describe a
    Date: (2022)
    Authors: Matthew J. Ford , Yojiro Yamanaka
    Ref: Stem Cell Assays
  9. DNA methylation is an epigenetic modification with an established role in both normal cellular function and mammalian disease. Despite well-characterized associations between aberrant DNA methylation changes and gene expression, evidence for a causal
    Date: (2022)
    Authors: Jim Smith , Rakesh Banerjee , Robert J. Weeks , Aniruddha Chatterjee
    Ref: Chromatin
  10. Date: 2023-11-06
    Authors: Papaioannou VE, Behringer RR.
    Journal: Cold Spring Harbor protocols
first · previous · 64 · 65 · 66 · 67 · 68 · 69 · 70 · 71 · 72 · 73 · next · last